Genome sequence reveals anti-HIV-1 integrase compounds in extremotolerant actinobacterium from desert soil, indicating potential therapeutic use.
We report the draft genome sequence of Lentzea sp. H45, an extremotolerant actinobacterium from high-altitude Atacama Desert soil, producing anti-HIV-1 integrase lentzeosides. The genome comprises 8.7 Mbp with 70.9% GC content and harbors 34 biosynthetic gene clusters, including a putative oligosaccharide cluster for lentzeoside biosynthesis.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: